ALVOW - Alvotech


0.31
0.080   25.806%

Share volume: 37
Last Updated: 03-26-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.04%

PREVIOUS CLOSE
CHG
CHG%

$0.23
0.08
0.35%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
24.00%
1 Month
-20.51%
3 Months
-47.46%
6 Months
-74.17%
1 Year
-80.13%
2 Year
-89.67%
Key data
Stock price
$0.31
P/E Ratio 
0.00
DAY RANGE
$0.25 - $0.31
EPS 
N/A
52 WEEK RANGE
$0.15 - $3.00
52 WEEK CHANGE
-$79.47
MARKET CAP 
2.854 B
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.05
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$3,524
AVERAGE 30 VOLUME 
$2,806
Company detail
CEO: Mark L. PhD
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

N/A

Recent news